Revised College Statements

The following revised statements were approved by RANZCOG Council and Board in July 2017:

• Measurement of cervical length in pregnancy for prediction of preterm birth (C-Obs 27)
  Revisions include:

1. A patient summary
2. A summary of recommendations
3. Strengthening of recommendations regarding cervical length assessment and measurement technique
4. Evidence that transabdominal assessment may be sufficient as a first-line screening test, potentially reducing the need for transvaginal assessment in a proportion of women

• Progesterone use in the second trimester for prevention of preterm birth (C-Obs 29b)
  Revisions include:

1. Strengthening of evidence that vaginal progesterone reduces the risk of preterm birth

• Maternity services in remote and rural communities (C-Obs 34)
  Revisions include:

1. Change of scope to include gynaecology services
2. Identifying community and workforce issues in rural and remote locations

• Delivery of the fetus at caesarean section (C-Obs 37)
  Revisions include:

1. Highlighting clinician awareness to certain circumstances that can increase the risk of fetal injury at caesarean section, including presenting part is deep in the pelvis
2. Highlighting importance of applying evenly distributed pressure on the fetal skull when disimpacting from the pelvis, by hand or inflatable devices

• Caesarean delivery on maternal request (C-Obs 39)
  Revisions include:

1. Recognising psychological factors that may heavily influence a woman’s informed choice
2. Strengthening the evidence on the effect of caesarean delivery on breastfeeding
3. Strengthening the evidence on the effect of cesarean delivery on maternal request on subsequent pregnancies

• Management of postpartum haemorrhage (C-Obs 43)
  Revisions include:

1. Addition of background physiology and aetiology
2. Addition of use of tranexamic acid and ‘Point of Care’ testing

• Intrauterine contraception (C-Gyn 3)
  Revisions include:

1. Incorporation of the importance of a follow-up visit at 3–6 weeks to exclude infection, perforation or expulsion
2. Aligned with Faculty of Sexual & Reproductive Healthcare Clinical Guidance

• Cervical Cancer Screening in Australia (C-Gyn 19)
  Revisions include:

1. Guidance on the Renewal of the National Cervical Screening Program

• Long-acting reversible contraception (LARC) (C-Gyn 34)
  Revisions include:

1. A patient summary
2. Strengthening of evidence for the use of implants and intrauterine contraception in young and nulliparous women and those immediately postpartum

• Patient record management on the discontinuation of practice (WPI 8)
  Revisions include:

1. Addition of state and territory regulatory and legislative requirements
2. Addition of ‘good practice notes’ regarding notice to patients and facilitating arrangements for ongoing care and transfer or management of records

A full list of College Statements can be viewed at www.ranzcog.edu.au/Statements-Guidelines.

RANZCOG Patient Information

There are currently 27 RANZCOG Patient Information Pamphlets available that can be viewed on the College website and ordered through a dedicated print store portal https://printstore.ranzcog.edu.au, with College members using their existing RANZCOG member number and registered email address.

The following new titles were approved for publication and are now available:

• Weight gain during pregnancy
• The first few weeks following birth
• Umbilical cord blood banking